1. Abbott Laboratories. (2006). Protocol No. M01-342: A double-blind, placebo-controlled trial to evaluate the safety and efficacy of Depakote ER for the treatment of mania associated with bipolar disorder in children and adolescents. Retrieved March 31, 2010, www.clinicalstudyresults.org.
2. Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont.
3. Almandil, N. B., Liu, Y., Murray, M. L., Besag, F. M., Aitchison, K. J., & Wong, I. C. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Pediatric Drugs, 15(2), 139–150.
4. American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: American Psychiatric Association.
5. American Psychological Association. (1993). Task force on promotion and dissemination of psychological procedures. In The meeting of the American Psychological Association.